The FDA issued a complete response letter to Genentech indicating it cannot approve the company’s biologic license ...

The FDA has declined to approve Columvi, in combination with the chemo regimen GemOx, for the treatment of second-line DLBCL patients who are not eligible for autologous stem cell transplant, Roche ...

The FDA determined the data from STARGLO did not provide sufficient evidence to support approving glofitamab-gxbm (Columvi) in combination with gemcitabine and oxaliplatin to treat relapsed/refractory ...

H.R. 1, known as the One Big Beautiful Bill Act, was signed into law this month and delivered critical portions of the Farm Bill for farmers ...

Based on a review of Fox news transcripts, the only brief mention of the blockbuster story was a tease by Laura Ingraham — who never came back to it after an ad break, writes Justin Baragona ...

AI is the bubble in the economy — it is devouring resources for data centres (expected to be close to a third of Irish electricity by 2026), mines our data and copyright rights are trampled aside by ...

This kind of resignation plays into the hands of Big Tech. Platforms that are knowingly hosting millions of under-13s — ...

Republican majorities in both houses of Congress have now approved President Donald Trump’s clawback of about $9 billion for ...

President Trump has taken an unconventional approach to trade negotiations by sending form letters to foreign leaders ...

For most world leaders, tariff letters from US President Donald Trump mean a big headache. But one Southeast Asian general is ...

As a member of the Colorado Springs Faith Table and Together Colorado, I believe — as do many neighbors — that residents ...

A group of well-known organizations published an open letter to the Prime Minister this weekend. Organizations like the EMA, ...